Caspase-activated DNase (CAD) degrades chromosomal DNA during apoptosis, whereas ICAD (inhibitor of CAD) inhibits the CAD's DNase by binding to it. Here, we describe the assignment of murine CAD and ICAD genes to the distal part of murine chromosome 4. Molecular cloning and structural analysis indicated that CAD and ICAD genes are comprised of 7 and 6 exons, respectively. Two different ICAD mRNAs coding for two forms of ICAD proteins (ICAD-S and ICAD-L) were found to be produced by alternative splicing of intron 5. The CAD and ICAD mRNAs were detected ubiquitously in various murine tissues. Analyses of the promoter activity with a series of deletion mutants of their 5' flanking regions indicated that a 190-bp 5' flanking region of the CAD gene was sufficient to promote the transcription. Whereas, a 120-bp flanking region of ICAD gene was required to promote its transcription. These regions do not show similarity between CAD and ICAD genes, suggesting that expression of CAD and ICAD genes is regulated by different mechanisms.
Introduction
Apoptosis is a cell death process that removes useless, harmful, or senescent cells from the body. 1 This process is characterized morphologically by cell shrinkage, chromatin condensation, and formation of apoptotic bodies, 2 and biochemically by degradation of chromosomal DNA into nucleosomal units. 3 Most of the apoptotic stimuli activate caspases, which are cysteine proteases that cleave various substrates such as poly(ADP) ribose polymerase, lamin, and fodrin to promote the apoptotic process. 4 ± 7 We and others recently showed that a DNase (CAD, caspase-activated DNase; also called CPAN, caspase activated nuclease, as well as DFF-40, DNA fragmentation factor-40) is activated during apoptosis, and cleaves the chromosomal DNA. 8 ± 12 In the growing, non-apoptotic cells, CAD is complexed with its inhibitor (ICAD, inhibitor of CAD; also called DFF-45) and predominantly localized in the cytoplasm. When cells are induced to die by apoptotic stimuli such as Fas ligand or the kinase inhibitor staurosporine, caspases are activated. The activated caspases cleave ICAD at two positions, which releases CAD from ICAD. 12 Murine and human CADs are comprised of 344 and 338 amino acids, respectively, with 76% identity. 8 ± 11 Murine ICAD exists in two forms ± long and short (ICAD-L and ICAD-S) which consist of 331 and 265 amino acids, respectively. 8 Murine ICAD-L is 76% identical to human DFF-45, 13 suggesting that murine ICAD is the murine counterpart of human DFF-45. In addition, CAD and ICAD have a homologous domain of about 100 amino acids at the N-terminus. 11 A similar domain has also been found in several proteins of unknown function. 14 In this report, we showed that the murine CAD and ICAD genes are localized close to one another on murine chromosome 4. The isolation and structural analysis of their chromosomal genes indicated that CAD and ICAD comprise about 11 and 16 kb DNA, and are split by 6 and 5 introns, respectively. A comparison of the ICAD chromosomal gene with its mRNAs indicated that the ICAD-L and ICAD-S mRNAs are generated by alternative splicing of intron 5. The CAD and ICAD genes are expressed ubiquitously in similar tissues. However, the 5' flanking sequences of CAD and ICAD genes necessary to promote the transcription were not well conserved between the two genes, suggesting that the expression of the CAD and ICAD genes is regulated differently.
Results
Assignment of CAD and ICAD genes on murine chromosome digested with several enzymes and analyzed by Southern blot hybridization for informative restriction fragment length polymorphisms (RFLPs) using murine cDNA probes. The 5.3 and 3.8 kb SphI M. spretus RFLPS (see Materials and Methods) were used to follow the segregation of the Icad locus and the 15.0 and 2.6 kb BglII fragments were used to follow the Cad locus in backcross mice. The mapping results indicated that the two genes are linked and are located in the distal region of murine chromosome 4 linked to Htrld, Nppa and Gnb1. Although 100 mice were analyzed for every marker and are shown in the segregation analysis (Figure 1 ), up to 178 mice were typed for some pairs of markers. Each locus was analyzed in pairwise combinations for recombination frequencies using the additional data. The ratios of the total number of mice exhibiting recombinant chromosomes to the total number of mice analyzed for each pair of loci and the most likely gene order are: centromere-Htrld-5/119-Nppa-0/ 109-Icad-1/160-Cad-3/178-Gnb1. The recombination frequencies [expressed as genetic distances in centiMorgans (cM)+the standard error] are -Htrld-4.2+1.8-[Nppa, Icad]-0.6+0.6-Cad-1.7+1.0-Gnb1. No recombinants were detected between Nppa and Icad in 109 animals typed in common suggesting that the two loci are within 2.8 cM of each other (upper 95% confidence limit).
Chromosomal gene structure of the murine CAD and ICAD genes
To determine the extron-intron organization of CAD and ICAD, DNA fragments carrying the CAD and ICAD chromosomal genes were isolated from a murine genomic library. Restriction-enzyme mapping and PCR analyses of these DNA fragments indicated the clones Q9 and P1 contain the entire CAD and ICAD chromosomal genes, respectively. A comparison of the genomic sequences with that of the CAD cDNA indicated that the murine CAD chromosomal gene consists of about 11 kb, and is split by six introns (Figure 2A ). The ICAD chromosomal gene was found to consist of about 16 kb, and to be split by five introns ( Figure 2B ). The nucleotide sequences of the coding region of chromosomal CAD was completely identical to the CAD cDNA sequence. The nucleotide sequence of the ICAD chromosomal gene carried two silent mutations at positions 249 (G ± A) and 378 (T ± C). All of the splice donor and acceptor sites conformed to the GTÐAG rule for nucleotides immediately flanking exon borders. 16 The N-terminal region of about 100 amino acids is homologous between CAD and ICAD. 11 This region was encoded by two exons in both CAD and ICAD.
There are two isoforms for murine ICAD mRNA (ICAD-L and ICAD-S), which code for proteins of 331 and 265 amino acids, respectively.
8 ICAD-S is the same as ICAD-L truncated at the 261 amino acid position, and carries an extra 4 amino acids at the C-terminus. The 3' non-coding region of the ICAD-S mRNA diverges from that of ICAD-L mRNA. A comparison of the nucleotide sequence of the ICAD chromosomal gene with ICAD-L and ICAD-S cDNAs indicated that ICAD-L mRNA contains exons 1 ± 6. In contrast, the ICAD-S mRNA contains only exon 1 ± 5, and its sequence continues into intron 5 ( Figure 2C ).
Expression of CAD and ICAD mRNAs in murine tissues
The tissue distribution of the CAD and ICAD mRNAs was examined by Northern hybridization. As shown in Figure 3A , most tissues were found to express an mRNA of about 2.5 kb that hybridized with the CAD probe. Some tissues such as spleen, thymus, small intestine and lymph nodes expressed a high level of CAD mRNA. The skeletal muscle also showed a strong band hybridizing with CAD probe, but its size (about 1 kb) was significantly smaller than that found in other tissues. When Northern hybridization was carried out with the coding sequence of ICAD cDNA, two bands of 3.8 and 2.3 kb were The promoter sequence of ICAD and CAD chromosomal genes
The 5' flanking sequences (660 and 730 bp, respectively) of the murine CAD and ICAD genes are shown in Figure 4A and B. To determine the transcription initiation sites for CAD and ICAD mRNAs, 5'-RACE procedure was carried out with mRNA from murine WR19L T cell lymphoma cells. As shown in Figure 4C , PCR with an anti-sense primer at 371 nucleotides downstream of the ATG initiation codon in the CAD cDNA produced a major band of 460 bp. The same procedure for ICAD mRNA with an antisense primer at 614 nucleotides downstream of the ATG codon gave a major band of 740 bp. The major PCR products for CAD and ICAD mRNAs were then subcloned and sequenced. Most of the PCR products for CAD mRNA started around the G at position +1, 43 nucleotides upstream from the initiation codon, while minor PCR products (less than 10%) started from the G at position 737 ( Figure 4A ). On the other hand, most of the PCR products for ICAD mRNA started from the A at position +1, 88 nucleotides upstream from the initiation codon ( Figure 4B ). These bases were therefore tentatively assigned as the transcription initiation sites for CAD and ICAD mRNAs. There is no`TATA-like' box immediately upstream of the transcription initiation site in either the CAD or ICAD gene. A sequence of about 500 nucleotides up to position 7600 in the CAD gene is extremely rich in G and C nucleotides (75% G/C). In contrast, the 5' promoter region of the ICAD gene was rich in A and T nucleotides (42% G/C). There was a B1-like repetitive sequence of about 340 bp at 320 nucleotides upstream of the transcription initiation site of the ICAD gene.
Promoter analysis of CAD and ICAD genes in human HeLa and Jurkat cells
To examine the promoter activity of the 5' flanking region of CAD and ICAD genes, a 544-bp fragment carrying the sequence of 7590 to 746 of CAD gene or a 297-bp fragment carrying the sequence of 7305 to 78 of ICAD gene was introduced into the upstream of the luciferase reporter gene (pBPA). As shown in Figure 5A ,
To determine regulatory elements in this region, a series of deletion mutants in the 5' flanking region of the CAD gene was then joined to luciferase gene, and the promoter activity was assayed. As shown in Figure 5A , deletion of the sequence from 7590 to 7190 had no significant effect on the promoter activity. On the other hand, the deletion of the sequence from 7189 to 7133 caused a sixfold or threefold reduction of the promoter activity in HeLa and Jurkat cells, respectively. These results suggest that a transcriptional regulatory element(s) are on the region from 7189 to 7133 of the CAD gene.
The 297-bp DNA fragment of the 5' flanking region of ICAD gene in pICADP plasmid also stimulated transcription of the luciferase gene about 100 times and 30 times in HeLa and Jurkat cells, respectively ( Figure 5B ). Activation of transcription by a longer fragment containing the sequence up to 3.7 kb was similar to that obtained with the 297-bp fragment (data not shown), suggesting that the transcription of ICAD gene is controlled by the 297-bp fragment in the upstream of the transcription initiation site. Deletion of the sequence from 7305 to 7119 had little effect on the promoter activity. Further deletion up to 780 caused a significant reduction of the promoter activity in HeLa cells, although its effect in Jurkat cells were less significant. Whereas, when the sequence was further deleted up to 756, the promoter activity dropped in both HeLa and Jurkat cells.
Discussion
Murine and human CAD have an identity of 76% at the amino acid sequence level. We previously showed that there are intact and processed pseudo genes for human CAD. 11 The intact human CAD gene is localized on the short arm of chromosome 1 (1p36.3). 11 Here, we cloned a single introncontaining gene for murine CAD, and assigned it to the distal part of murine chromosome 4, which is syntenic to the short arm of human chromosome 1 (1p36). These results suggest that there is a single functional gene for CAD per murine haploid genome. Murine ICAD inhibits the CAD's DNase activity, and has an identity of 76.1% with human DFF-45, one of the subunits of DNA fragmentation factor in apoptosis. 13 We A B C Figure 3 Expression of the CAD and ICAD mRNAs in murine tissues. Poly(A) RNA was prepared from the indicated tissues by using the Quick Prep TM micro mRNA preparation kit (Pharmacia). Two micrograms of RNA from each source was subjected to electrophoresis and analyzed by Northern hybridization as described previously.
28 32 P-labeled murine CAD cDNA (A) or ICAD-L cDNA (B) was used as the probe. The filter was stained with methylene blue, and is shown in (C). The positions of 28S and 18S rRNAs are indicated by arrows on the right cloned an intron-containing gene for murine ICAD, and showed that it is closely localized with the CAD gene on murine chromosome 4. Human DFF-45 was recently assigned to the region of 1p36. 3, 17 where the CAD gene is located. 11 These (C) Figure 4 The 5' flanking region of the CAD and ICAD chromosomal genes. (A and B) Nucleotide sequence of the 5' flanking region of murine CAD (A) and ICAD (B) chromosomal genes. The nucleotide sequence is numbered from the major transcription initiation site. The major transcription initiation site is indicated by a bold arrow, while the minor initiation site is indicated by a thin arrow. The B1-like repetitive sequence in ICAD gene is doubly underlined. The binding sites for transcription factors were identified with MatInd and MatInspector programs, 29 and are underlined. (C) 5' RACE procedure for the CAD and ICAD mRNAs. Poly(A) RNA from murine WR19L cells were reverse-transcribed with an anti-sense primer specific for CAD (lanes 2 ± 5) or ICAD (lanes 6 ± 9), and subjected to the 5' RACE procedure as described in Materials and Methods. PCR was carried out with a specific anti-sense primer (AS07 for CAD and AS3 for ICAD) and a sense primer (AP1) in the adaptor (lanes 4 and 8) . As controls, PCR was carried out with the anti-sense primer alone (lanes 2 and 6) or the sense adaptor primer alone (lanes 3 and 7). PCR was also carried out with the sense and anti-sense primers (AS07 and S13 for CAD, and AS3 and S7 for ICAD) that are specific to the CAD or ICAD mRNA, respectively (lanes 5 and 9). The DNA size marker (100 bp DNA ladder, New England Biolabs) was subjected to electrophoresis in parallel, and the size is shown on the right in bp. An arrow indicates the origin of electrophoresis Structure and expression murine CAD and ICAD genes K Kawane et al results suggest that human DFF-45 is the human ortholog of ICAD, and that there is a single chromosomal gene for ICAD per murine haploid genome. We have compared our interspecific map of chromosome 4 with a composite murine linkage map that reports the map location of many uncloned murine mutations (provided from Murine Genome Database, a computerized database maintained at The Jackson Laboratory, Bar Harbor, ME, USA). Icad and Cad were mapped in a region of the composite map that lacks murine mtuations with a phenotype that might be expected for an alteration in these loci (data now shown).
ICAD, which is more abundant than CAD, can bind to CAD. 8, 12 In growing cells, CAD exists as a complex with ICAD, 10, 13, 18 suggesting that CAD and ICAD function as subunits. The N-terminal domain of about 100 amino acids is homologous between CAD and ICAD. However, no homology is apparent between the other parts of these molecules. 11 Nonetheless, CAD and ICAD are localized in the same chromosomal region in human and mouse. Since functional CAD cannot be synthesized without ICAD, 8, 18 CAD and ICAD may have evolved as a set of genes. To further examine this possibility, it would be necessary to determine the detailed arrangement of the CAD and ICAD genes on human and murine chromosomes, as well as on the chromosomes of other organisms. The N-terminal homologous domain of CAD and ICAD is coded by two exons in both genes, and introns in this domain are inserted at similar positions in the CAD and ICAD genes. However, intron 1 is inserted after the third letter of a codon in the CAD gene, while it is inserted after the first letter of a codon in the ICAD gene, suggesting that this domain may not have derived from a common ancestral gene. Rather, the sequence encoding the N-terminal portions of CAD and ICAD may have converged from different ancestral genes to a similar sequence to acquire a similar function. Although the function of the N-terminal domain of CAD and ICAD has not yet been elucidated, it is possible that it works as a homophilic interacting domain as found for the death and CARD domains. 19 ± 21 Structural analysis of the murine ICAD gene indicated that two different mRNAs for ICAD (ICAD-L and ICAD-S) are generated by alternative splicing of intron 5. ICAD-L and ICAD-S mRNAs were expressed at a similar level in various murine tissues. Equal amounts of ICAD-S and ICAD-L proteins were also detected by Western blotting in human and murine cell lines, 18, 22 suggesting that the human ICAD gene also produces ICAD-S and ICAD-L mRNAs by alternative splicing. We have recently found that ICAD-L but not ICAD-S has an ability to work as a chaperone to enhance the correct folding of the CAD protein during CAD synthesis, although both ICAD-L and ICAD-S proteins efficiently inhibit the CAD' DNase activity. 18 Whether ICAD-S has a specific function or not, remains to be determined.
Murine CAD and ICAD mRNAs were expressed rather ubiquitously in various tissues, although its expression level in the lymphocytic tissues such as the thymus, spleen and lymph nodes was relatively high. Yet, the characteristics of the 5' flanking promoter region were significantly different between the CAD and ICAD genes. The promoter region of the murine CAD gene was very G and C rich as found in many ubiquitous house-keeping genes. On the other hand, the G and C content in the promoter region of murine ICAD was much lower than for CAD. The promoter analysis of the CAD and ICAD genes indicated that the sequence up to 7189 of the CAD gene is sufficient to stimulate the transcription in HeLa and Jurkat cells. Several cis-regulatory elements for binding of various transcription factors such as RFX-1, SP-1, AP-2, MZF-1 and Ets are in this region. The ICAD gene expression required the sequence between 7118 and 78 of the ICAD gene, in which binding sites for Ikaros, cRel, Myc and Gfi-1 can be found. Except for MZF-1 and Ikaros, these transcription factors are rather ubiquitously expressed in various tissues, as found for CAD and ICAD genes. Although it will be necessary to determine which transcription factors are responsible for the expression of the respective genes, these results suggest that expression of CAD and ICAD genes are regulated by different mechanisms.
Materials and Methods
Isolation of murine chromosomal genes for CAD and ICAD
4610
5 plaques of lFIXII carrying a genomic DNA fragment from 129/ SV mice (Stratagene, La Jolla, CA, USA) were screened under high stringency conditions using a DNA fragment carrying murine CAD or ICAD-L cDNA 8 as probes. Recombinant lDNAs that were positive with BPA represents pBPA-TATALuc vector. 27 The promoter activity of each construct was determined in HeLa and Jurkat cells, and relative luciferase activities are expressed as a percentage of that of pCADP (A) or pICADP (B), respectively. Transfection was done four times, and the average values are shown with standard deviation the probe were subcloned into pBluescript II, characterized by restriction enzyme mapping and PCR (polymerase chain reaction) using primers in exons. The DNA appropriate DNA fragments were then characterized by DNA sequencing analysis.
Hybridization and DNA sequencing
Colony, plaque, and Northern hybridizations were carried out as described previously. 23 The probe DNA was prepared by PCR using the appropriate plasmid DNA as a template, and labeled with a-32 PdCTP (New England Nuclear, Wilmington, DE, USA) using a random primer labeling kit (Boehringer Mannheim, Germany). DNA sequencing was carried out using a DNA sequencer (model 373A, Applied Biosystems, Foster City, CA, USA) and a Taq DyeDeoxy Terminator cycle sequencing kit (Applied Biosystems).
5' RACE
The 5'-RACE was carried out using a kit from Clontech Laboratories (Palo Alto, CA, USA) according to the protocol provided. In brief, the first-strand cDNA was synthesized using a primer (5'-CTGGCTCA-CATGATGTAGGAGATC-3') at the nucleotide position of 373 ± 396 for CAD, and a primer (5'-GATAAACTCAGCTCTGG-3') at the nucleotide position of 751 ± 767 for ICAD. The CAD-and ICAD-specific cDNAs were then amplified using a primer (ASO7; 5'-GGCCAG-CAGCTTTTGCCTCAG-3') at the nucleotide position of 352 ± 372, and a primer (AS3; 5'-TCCACTTCTCATTGCAGGCC-3') at the nucleotide position of 264 ± 283, respectively. The PCR products were cloned in pGEM R -T Easy Vector (Promega, Madison, WI, USA), and their DNA sequences were determined.
Interspeci®c murine backcross mapping
Interspecific backcross progeny were generated by mating (C57BL/ 6J6M. spretus) F 1 females and C57BL/6J males as described. 15 A total of 205 N 2 mice were used to map the Icad and Cad loci (see text for details). DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, Southern blot transfer and hybridization were performed essentially as described. 24 All blots were prepared with Hybond-N + nylon membrane (Amersham, Arlington Heights, IL, USA). The probe for Icad was an about 1.1 kb fragment of murine cDNA and the probe for Cad was an about 1.6 kb fragment of murine cDNA. The probes were labeled with a 32 P-dCTP using a nick translation labeling kit (Boehringer Mannheim); washing was done to a final stringency of 0.8 ± 1.06SSCP, 0.1% SDS, 658C. Fragments of 21.0 and 3.6 kb were detected in SphI digested C57BL/6J (B) DNA and a fragments of 5.3, 3.8 and 3.6 kb were detected in SphI digested M. spretus (S) DNA using the Icad probe. BglII fragments of 11.0, 1.8, and 1.5 (B) and 15.0 and 2.6 kb (S) were detected with Cad probe. The presence or absence of the M.spretus-specific fragments, which co-segregated for each probe, was followed in backcross mice.
A description of the probes and RFLPs for the loci linked to Icad and Cad including Htrld, Nppa and Gnb1 has been reported previously. 25, 26 Recombination distances were calculated using Map Manager, version 2.6.5. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
Transfection and luciferase assay
A series of fragments containing various length of the 5' flanking region of murine CAD and ICAD genes were prepared by PCR. After confirming its authenticity by DNA sequencing, they were joined to the luciferase gene in pBPA-TATALuc vector, which contains a TATA box derived from murine G-CSF gene upstream of the firefly luciferase gene. 27 Human HeLa and Jurkat cell lines were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum (FCS, Gibco BRL) or RPMI1640 medium containing 10% FCS, respectively. HeLa cells (5610 3 cells) were transfected with 500 ng of the reporter plasmid by lipofection using spherical cationic polyamidoamine polymers (SuperFect Transfection Reagent, QIAGEN). As an internal control of the transfection, 100 ng of pBOS-Rluc plasmid carrying the sea pansy luciferase gene (Promega) in pEF-BOS vector was included in each transfection. After culturing cells at 378C for 24 h, the luciferase activity in the cell lysates was measured using Dual Promoter Luciferase Assay Kit from Promega. The firefly luciferase activity of each sample was normalized to the sea pansy luciferase activity. Jurkat cells (4610 5 cells) were transfected with 1 mg of the reporter plasmid and 200 ng of the pBOS-Rluc plasmid by the lipofection method using DIMREA-C Reagent from Gibco BRL. Cells were cultured at 378C for 30 h, then the luciferase activity in the cell lysates was measured as described above.
